Chargement en cours...

Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer

BACKGROUND: As one of the many breast cancer subtypes, human epidermal growth factor receptor 2 (Her2)-positive breast cancer has higher invasiveness and poor prognosis, although the advent of anti-Her2 drugs has brought good news to patients. However, the emergence of drug resistance still limits i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Cell Int
Auteurs principaux: Gao, Chundi, Zhuang, Jing, Li, Huayao, Liu, Cun, Zhou, Chao, Liu, Lijuan, Feng, Fubin, Sun, Changgang, Wu, Jibiao
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7161270/
https://ncbi.nlm.nih.gov/pubmed/32322168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01175-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!